Scarica l'app Stockscreener
2.87
0.00%
0.00
Precedente Chiudi:
$2.87
Aprire:
$2.87
Volume 24 ore:
20,000
Relative Volume:
0.02
Capitalizzazione di mercato:
$65.29M
Reddito:
-
Utile/perdita netta:
$-55.99M
Rapporto P/E:
-1.1474
EPS:
-2.5013
Flusso di cassa netto:
$-47.60M
1 W Prestazione:
+1.41%
1M Prestazione:
+6.10%
6M Prestazione:
+151.75%
1 anno Prestazione:
+153.98%
Intervallo 1D:
$2.86
$2.89
Intervallo di 1 settimana:
$2.80
$2.94
Portata 52W:
$0.9612
$3.1636
Boundless Bio Inc Stock (BOLD) Company Profile
Nome
Boundless Bio Inc
Settore
Industria
Telefono
(858) 766-9912
Indirizzo
10955 ALEXANDRIA WAY, SAN DIEGO
Compare BOLD vs VRTX, REGN, ARGX, MRNA, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BOLD
Boundless Bio Inc
|
2.87 | 65.97M | 0 | -55.99M | -47.60M | -2.5013 |
VRTX
Vertex Pharmaceuticals Inc
|
546.12 | 136.93B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
827.72 | 85.11B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,033.15 | 64.95B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
145.55 | 53.23B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
210.02 | 45.38B | 742.00K | -1.37B | -1.07B | -7.0731 |
Boundless Bio Inc Stock (BOLD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-02 | Iniziato | H.C. Wainwright | Buy |
| 2025-05-28 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-12-13 | Downgrade | Guggenheim | Buy → Neutral |
| 2024-04-22 | Iniziato | Guggenheim | Buy |
| 2024-04-22 | Iniziato | Leerink Partners | Outperform |
| 2024-04-22 | Iniziato | Piper Sandler | Overweight |
Mostra tutto
Boundless Bio Inc Borsa (BOLD) Ultime notizie
Boundless (BOLD) Session: Climbs 1.40% to $2.90 in the Current Update; Trading Range: Price Remains Between $2.75 Support and $3.04 Resistance on the DayFactor Timing - vinanet.vn
Boundless (BOLD) Results Versus Estimates: Profit Per Share Falls Below Its Benchmark in the Available Record; Shares Show Limited Movement under the Current SnapshotFiscal Year Earnings - vinanet.vn
Boundless Bio (BOLD): ADAR1 Capital discloses 8.8% beneficial ownership stake - Stock Titan
Boundless Bio (BOLD): Citadel entities and Ken Griffin report 0.6% ownership - Stock Titan
Boundless Bio (BOLD) Edges Up to $2.79 as Stock Holds Tight Trading RangeTriple Bottom - Vinanet
Boundless Bio, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Boundless Bio Inc (BOLD) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Boundless Bio, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
Boundless Bio, Inc. 2Q 2026: Net loss $23.7M, EPS $(1.06) — 10-Q Summary - TradingView
Boundless Bio (Nasdaq: BOLD) plans Serapha merger and dividend - Stock Titan
Boundless Bio (BOLD) Advances 3.57% to $2.90 as Support at $2.75 HoldsBPI Bull Correction - vinanet.vn
Boundless Bio, Inc. Revenue Breakdown – NASDAQ:BOLD - TradingView
Boundless Bio Inc expected to post a loss of 58 cents a shareEarnings Preview - TradingView
Boundless Bio Inc (BOLD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Boundless Bio Inc (BOLD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
BOLD|Boundless Bio Inc|Price:2.485|Chg%:-0.085 - TradingKey
Boundless Bio Inc (BOLD) Valuation: PE, PB & Fair Value Analysis - TradingKey
Boundless Bio Inc (BOLD) Institutional Confidence - TradingKey
Boundless Bio Inc (BOLD) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Boundless Bio Inc (BOLD) Balance Sheet - tradingkey.com
BOLD|Boundless Bio Inc|Price:2.580|Chg%:+0.010 - TradingKey
TradingKey - TradingKey
Boundless Bio Inc (BOLD) Income Statement - TradingKey
Boundless Bio Inc (BOLD) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Boundless Bio director Kevin Tang buys $11,865 in shares By Investing.com - Investing.com South Africa
Major Investor Quietly Boosts Stake in Emerging Biotech Player - TipRanks
Form 4 Boundless Bio Inc For: 21 July By Investing.com - Investing.com South Africa
Boundless Bio 10% owner Kevin Tang acquires $11,876 in common shares - Bitget
Boundless Bio director Kevin Tang buys $11,865 in shares - Investing.com
Boundless Bio (NASDAQ: BOLD) major Tang Capital holder adds 4,863 shares - Stock Titan
BOLD Q1 2026 Earnings: EPS Misses Estimates as Pre-Revenue Biotech Advances PipelineEarnings Quality Analysis - vinanet.vn
Boundless Bio Inc. (BOLD) Q1 2026 Earnings: EPS Misses Estimates, Shares Dip Amid Clinical-Stage ChallengesReturn On Assets - dars.gov.et
Boundless Bio Inc. (BOLD) Holds Near Support After Modest DeclineBuyback Factor - dars.gov.et
Tang Capital’s Kevin Tang reports $154,586 Boundless Bio common share purchase - Bitget
Boundless Bio: ten percent owner Kevin Tang buys $155,645 By Investing.com - Investing.com South Africa
Boundless Bio: ten percent owner Kevin Tang buys $155,645 - Investing.com
63,969 shares bought by Tang Capital in Boundless Bio, Inc. (BOLD) - Stock Titan
Form 4 Boundless Bio Inc For: 13 July By Investing.com - Investing.com Nigeria
Tang capital management, Kevin Tang buy $222k Boundless Bio stock By Investing.com - Investing.com Nigeria
Tang capital management, Kevin Tang buy $222k Boundless Bio stock - Investing.com
Boundless Bio (BOLD) Gains 2.45% as Shares Approach Key ResistanceRelative Volume - DonanımHaber
Kevin Tang’s Tang Capital buys $141,864 in Boundless Bio (BOLD) By Investing.com - Investing.com Nigeria
Form 4 Boundless Bio Inc For: 8 July By Investing.com - Investing.com Canada
Ten percent owner of Boundless Bio (NASDAQ: BOLD) adds shares - Stock Titan
Kevin Tang’s Tang Capital buys $141,864 in Boundless Bio (BOLD) - Investing.com
Boundless Bio Inc. (BOLD) Holds Steady at $2.50: Navigating Key Support and Resistance LevelsTechnical Analysis - DonanımHaber
Boundless Bio to merge with Serapha Bio in reverse merger; shares surge - MSN
Form 4 Boundless Bio Inc For: 6 July By Investing.com - Investing.com Nigeria
Boundless Bio ten percent owner Kristina Burow sells $39,840 in stock - Investing.com
Arch venture funds sell $39,840 in Boundless Bio stock - Investing.com
Form 4 Boundless Bio Inc For: 6 July - Investing.com India
Boundless Bio Inc Azioni (BOLD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Boundless Bio Inc Azioni (BOLD) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| TANG KEVIN | 10% Owner |
Jul 21 '26 |
Buy |
2.44 |
2,975 |
7,259 |
2,858,935 |
| TANG KEVIN | 10% Owner |
Jul 20 '26 |
Buy |
2.44 |
1,623 |
3,960 |
2,855,960 |
| TANG KEVIN | 10% Owner |
Jul 17 '26 |
Buy |
2.44 |
265 |
647 |
2,854,337 |
| TANG KEVIN | 10% Owner |
Jul 14 '26 |
Buy |
2.43 |
43,878 |
106,624 |
2,833,981 |
| TANG KEVIN | 10% Owner |
Jul 16 '26 |
Buy |
2.44 |
18,491 |
45,118 |
2,854,072 |
| TANG KEVIN | 10% Owner |
Jul 15 '26 |
Buy |
2.44 |
1,600 |
3,904 |
2,835,581 |
| TANG KEVIN | 10% Owner |
Jul 13 '26 |
Buy |
2.42 |
48,211 |
116,671 |
2,790,103 |
| TANG KEVIN | 10% Owner |
Jul 10 '26 |
Buy |
2.43 |
43,367 |
105,382 |
2,741,892 |
| TANG KEVIN | 10% Owner |
Jul 09 '26 |
Buy |
2.48 |
7 |
17 |
2,698,525 |
| TANG KEVIN | 10% Owner |
Jul 06 '26 |
Buy |
2.49 |
27,062 |
67,384 |
2,668,370 |
0.86%
0.31%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):